Addressing Healthcare Inequities™: Tailoring Management Plans to Address Healthcare Disparities in Cystic Fibrosis

Thanks for your interest in this podcast. Please read this important program information before listening. Access to the post-test and to claim credit for participating is included below.

This PER® Spectives™ podcast includes a discussion with 3 experts on health disparities that negatively impact patients with cystic fibrosis (CF). Access to care, insurance costs, and unintended bias are just some of the factors that contribute to the existence and persistence of these disparities. This program is designed to help clinicians better recognize and take steps to address ethnic and racial disparities, as well as social and economic inequities, in CF, thereby forwarding progress to improve patient outcomes.

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Educational Grant Support

This activity is supported by an educational grant from Vertex Pharmaceuticals.

Target Audience 

This educational activity is directed toward CF specialists, pulmonologists, pediatricians, gastroenterologists, nurse practitioners, physician assistants, nurses, and other clinicians who provide care for patients with cystic fibrosis.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to: 

• Identify patients who are at risk of CF healthcare disparities
• Analyze clinical trial data for current and emerging therapies for the treatment of cystic fibrosis
• Design individualized multidisciplinary management plans for patients with cystic fibrosis who experience healthcare disparities

Chair:

Emily DiMango, MD
Professor of Medicine 
Director, Adult Cystic Fibrosis Program
Columbia University Medical Center
New York, NY

Disclosures: Grant/Research Support: Vertex Pharmaceuticals. Other Support: Site investigator for clinical trial.

Faculty:

Clement L. Ren, MD, MBA
Professor of Pediatrics 
University of Pennsylvania Perelman School of Medicine
Cystic Fibrosis Center Director 
Children’s Hospital of Philadelphia
Philadelphia, PA

Disclosures: Grant/Research Support: Vertex Pharmaceuticals. Consultant: AbbVie, MannKind Corporation, Takeda, Vertex Pharmaceuticals, Vyaire Medical.

Winsome Sewell, LCSW
Senior Social Worker 
Cystic Fibrosis Center 
Morgan Stanley Children’s Hospital of New York Presbyterian
New York, NY

Disclosures:  Winsome Sewell, LCSW has no relevant financial relationships with ineligible companies.

The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies. 

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Release Date

January 30, 2023

Expiration Date

January 30, 2024

https://www.gotoper.com/ahi-fc-podcast